XML 23 R6.htm IDEA: XBRL DOCUMENT v3.8.0.1
CONSOLIDATED STATEMENT OF CASH FLOWS - USD ($)
$ in Thousands
12 Months Ended
Apr. 28, 2018
Apr. 29, 2017
Apr. 30, 2016
Cash flows from operating activities      
Net income $ 81,595 $ 86,984 $ 80,963
Adjustments to reconcile net income to cash provided by operating activities      
(Gain) loss on disposal of assets (2,108) (224) 384
Gain on conversion of investment (2,204)    
Gain on sale of investments (770) (471) (436)
Change in deferred taxes 17,261 569 4,581
Change in provision for doubtful accounts 276 (291) (660)
Depreciation and amortization 31,767 29,131 26,517
Stock-based compensation expense 9,474 8,864 8,292
Pension plan contributions (2,000) (2,300) (7,000)
Change in receivables (2,801) (7,850) 10,730
Change in inventories (8,009) 12,517 (14,621)
Change in other assets (3,245) (1,211) 4,148
Change in accounts payable 6,602 4,541 (1,007)
Change in other liabilities (10,088) 17,731 2,618
Net cash provided by operating activities 115,750 147,990 114,509
Cash flows from investing activities      
Proceeds from disposals of assets 1,440 761 3,054
Proceeds from property insurance 2,087    
Capital expenditures (36,337) (20,304) (24,684)
Purchases of investments (28,593) (29,763) (21,009)
Proceeds from sales of investments 22,674 19,954 28,721
Acquisitions, net of cash acquired (16,495) (35,878) (23,311)
Net cash used for investing activities (55,224) (65,230) (37,229)
Cash flows from financing activities      
Payments on debt (262) (288) (508)
Payments for debt issuance costs (231)    
Stock issued for stock and employee benefit plans, net of shares withheld for taxes 2,977 1,749 (1,728)
Excess tax benefit on stock option exercises   1,737 1,264
Purchases of common stock (56,730) (35,957) (44,082)
Dividends paid (22,009) (20,655) (18,141)
Net cash used for financing activities (76,255) (53,414) (63,195)
Effect of exchange rate changes on cash and equivalents 1,741 178 (688)
Change in cash, cash equivalents and restricted cash (13,988) 29,524 13,397
Cash, cash equivalents and restricted cash at beginning of period 150,859 121,335 107,938
Cash, cash equivalents and restricted cash at end of period 136,871 150,859 $ 121,335
Supplemental disclosure of non-cash investing activities      
Capital expenditures included in accounts payable $ 5,667 $ 1,795